Control of COPD. PawełŚliwiński. Institute of Tuberculosis and Lung Diseases Warsaw, Poland

Size: px
Start display at page:

Download "Control of COPD. PawełŚliwiński. Institute of Tuberculosis and Lung Diseases Warsaw, Poland"

Transcription

1 Control of COPD PawełŚliwiński Institute of Tuberculosis and Lung Diseases Warsaw, Poland

2 Elements of proper control Recognition Epidemiology Prevention Smoking cessation Early detection Education Physicians Diagnosis Management Patients

3 Some facts about Poland Population: 38,18 mln GDP: USD Life expectancy: F 79y M 71y COPD prevalence: 10% in > 40y old Expenditure on health as % of OECD average: 31% (744 USD)

4 Prevalence of smoking in Poland , adults(>15 years) percentage Males Females year

5 National Program of Early Detection and Prevention of COPD Zieliński J et al., ERJ 2006

6 Target group Setting Intervention Smokers, aged> 40 y Outpatient Chest Clinics Spirometry: FEV 1, FVC Antismoking advice Financing Costs National Health Fund 7 /person screened

7 Structure Ministry of Health Institute of TB and Lung Diseases Chest Clinics National Health Fund (NFZ)

8 Program Flowchart Questionnaire Spirometry FVC, FEV 1, FEV 1 /FVC Physician: evaluation of spirometry, antismoking advice FEV 1 /FVC<0.7 Spirometry normal Referral to family physician for further evaluation and treatment Follow-up after 1 year

9 Results (1) Subjects screened 105,190 Age 54±13 years M/F 57:43 Current smokers 62% Ex-smokers 28% Non-smokers 10% Tobacco exposure 27 ± 12 packyears Airflow limitation 21%

10 Results (2) Airflow limitation mild, FEV 1 >80% N moderate, FEV 1 =80-50% N severe, FEV 1 <50% N severe 69% normal 10% restriction moderate 6.3% 6.9% mild 7.8% AFL 21%

11 Prevention of COPD program launched by NHF Primary care physicians are encouraged to perform spirometry in their patients aged years Smokers (>10 packyears) Chronic cough and/or SOB on exertion All subjects with abnormal spirometry, FEV 1 /FVC< LLN are referred to outpatient chest clinic for spirometry tests to confirm or exclude airways obstruction. Patients with FEV 1 >50% of pred. remain in primary care Patients with FEV 1 <50% of pred. are registered in chest clinic

12 ~ subjects investigated/year COPD diagnosed in ~20% Costs 7 for PCP 12 for chest clinic Detection of 1 COPD ~ 50

13 Polish Society of Phtisiopneumonology Board of PSP established Accreditation Committee in 2003 Main goals: - to work out recommendations and standards for spirometric test - to prepare accreditation criteria for labs and outpatient clinics performing spirometry - to ensure uniform method of performing and interpretation of spirometry all over the country, thus to increase a quality of provided services

14 Accreditation Committee: published standards for spirometry conducted 18 presentations of standards for 1500 physicians in 2005 and physicians were fully trained in 2006 first 5 laboratories obtained accreditation certificate in 2006

15 Association of COPD patients Building an awareness of COPD in Polish population Dissemination of knowledge about COPD Popularization of management methods in COPD Medical advices for COPD patients

16

17 School for COPD patients

18 Thank you

19 GOLD 2006 Patients should be identified as early in the course of the disease as possible. However, the benefits of community based spirometric screening, of either the general population or smokers, are still unclear

Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care

Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care Charley P. Starnes, RRT, RCP Clinical Respiratory Specialist- COPD Education Important Milestones July 2011-

More information

COPD and Asthma Differential Diagnosis

COPD and Asthma Differential Diagnosis COPD and Asthma Differential Diagnosis Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in America. Learning Objectives Use tools to effectively diagnose chronic obstructive

More information

FIBROGENIC DUST EXPOSURE

FIBROGENIC DUST EXPOSURE FIBROGENIC DUST EXPOSURE (ASBESTOS & SILICA) WORKER S MEDICAL SCREENING GUIDELINE Prepared By Dr. T. D. Redekop Chief Occupational Medical Officer Workplace Safety & Health Division Manitoba Labour & Immigration

More information

Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital

Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital Mahidol University Journal of Pharmaceutical Sciences 008; 35(14): 81. Original Article Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical

More information

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Geisinger Health System Case Study Profile Geisinger Health System is a physician-led, fully integrated healthcare

More information

Interpretation of Pulmonary Function Tests

Interpretation of Pulmonary Function Tests Interpretation of Pulmonary Function Tests Dr. Sally Osborne Cellular & Physiological Sciences University of British Columbia Room 3602, D.H Copp building 604 822-3421 sally.osborne@ubc.ca www.sallyosborne.com

More information

COPD is the fourth most common cause of death. Gender Bias in the Diagnosis of COPD*

COPD is the fourth most common cause of death. Gender Bias in the Diagnosis of COPD* Gender Bias in the Diagnosis of COPD* Kenneth R. Chapman, MD, FCCP; Donald P. Tashkin, MD, FCCP; and David J. Pye, PhD Background: COPD is thought to be more prevalent among men than women, a finding usually

More information

WAY OF WORKING LUNG PATIENTS

WAY OF WORKING LUNG PATIENTS WAY OF WORKING LUNG PATIENTS CELLO Leiden May 2011 Introduction CELLO, the cooperation of primary health care practitioners in Leiden and surroundings, is an organisation of independently working general

More information

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Geisinger Health System Case Study Organization Profile Geisinger Health System is a physician-led, fully integrated

More information

PULMONARY FUNCTION TESTS A Workshop on Simple Spirometry & Flow Volume Loops

PULMONARY FUNCTION TESTS A Workshop on Simple Spirometry & Flow Volume Loops PULMONARY FUNCTION TESTS A Workshop on Simple Spirometry & Flow Volume Loops YOU SHOULD READ THE FOLLOWING MATERIAL BEFORE Tuesday March 30 Interpretation of PFTs Learning Objectives 1. Specify the indications

More information

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) DuPage Medical Group Case Study Organization Profile Established in 1999, DuPage Medical Group (DMG) is a multispecialty

More information

National Learning Objectives for COPD Educators

National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators The COPD Educator will be able to achieve the following objectives. Performance objectives, denoted by the

More information

Current consensus guidelines, such as the Global. Office Spirometry Significantly Improves Early Detection of COPD in General Practice*

Current consensus guidelines, such as the Global. Office Spirometry Significantly Improves Early Detection of COPD in General Practice* Office Spirometry Significantly Improves Early Detection of COPD in General Practice* The DIDASCO Study Johan Buffels, MD; Jan Degryse, MD, PhD; Jan Heyrman, MD, PhD; and Marc Decramer, MD, PhD Study objectives:

More information

Pathway for Diagnosing COPD

Pathway for Diagnosing COPD Pathway for Diagnosing Visit 1 Registry Clients at Risk Patient presents with symptoms suggestive of Exertional breathlessness Chronic cough Regular sputum production Frequent bronchitis ; wheeze Occupational

More information

Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms

Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms Clinical Guideline Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians,

More information

Exploratory data: COPD and blood eosinophils. David Price: 9.23-9.35am

Exploratory data: COPD and blood eosinophils. David Price: 9.23-9.35am Exploratory data: COPD and blood eosinophils David Price: 9.23-9.35am Blood Eosinophilia in COPD The reliability and utility of blood eosinophils as a marker of disease burden, healthcare resource utilisation

More information

Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms

Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms Clinical Guideline Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians,

More information

Abnormalities Consistent with Asbestos-Related Disease Among Long-Term Demolition Workers

Abnormalities Consistent with Asbestos-Related Disease Among Long-Term Demolition Workers Abnormalities Consistent with Asbestos-Related Disease Among Long-Term Demolition Workers Stephen M. Levin, M.D. Mount Sinai School of Medicine New York, New York November 1994 The Center to Protect Workers

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical

More information

Breathing Easier In Tennessee: Employers Mitigate Health and Economic Costs of Chronic Obstructive Pulmonary Disease

Breathing Easier In Tennessee: Employers Mitigate Health and Economic Costs of Chronic Obstructive Pulmonary Disease Breathing Easier In Tennessee: Employers Mitigate Health and Economic Costs of Chronic Obstructive Pulmonary Disease By John W. Walsh, Co-Founder and President of the COPD Foundation Breathing Easier In

More information

Draft Law on Public Health

Draft Law on Public Health Draft Law on Public Health Tadeusz Jędrzejczyk, PhD, MD CEO of the National Health Fund, Poland Brussels, 2 September 2015 Context No substantial health care system reform over the past 25 years - interventional

More information

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Reliant Medical Group Case Study Organization Profile Reliant Medical Group (formerly Fallon Clinic) was founded in

More information

Chapter 7: Effect Modification

Chapter 7: Effect Modification A short introduction to epidemiology Chapter 7: Effect Modification Neil Pearce Centre for Public Health Research Massey University Wellington, New Zealand Chapter 8 Effect modification Concepts of interaction

More information

Spirometry Workshop for Primary Care Nurse Practitioners

Spirometry Workshop for Primary Care Nurse Practitioners Spirometry Workshop for Primary Care Nurse Practitioners Catherine Casey S. Jones PhD, RN, AE-C, ANP-C Certified Adult Nurse Practitioner Texas Pulmonary & Critical Care Consultants P.A. and Visiting Assistant

More information

1 ALPHA-1. What is Alpha-1? A family history... of lung disease? of liver disease? FOUNDATION

1 ALPHA-1. What is Alpha-1? A family history... of lung disease? of liver disease? FOUNDATION What is Alpha-1? A family history... of lung disease? of liver disease? What you need to know about Alpha-1 Antitrypsin Deficiency 1 ALPHA-1 FOUNDATION What is Alpha-1? Alpha-1 Antitrypsin Deficiency (Alpha-1)

More information

3/11/15. COPD Disease Management Tackling the Transition. Objectives. Describe the multidisciplinary approach to inpatient care for COPD patients

3/11/15. COPD Disease Management Tackling the Transition. Objectives. Describe the multidisciplinary approach to inpatient care for COPD patients Faculty Disclosures COPD Disease Management Tackling the Transition Dr. Cappelluti has no actual or potential conflicts of interest associated with this presentation. Jane Reardon has no actual or potential

More information

GCE AS/A level 1661/01A APPLIED SCIENCE UNIT 1. Pre-release Article for Examination in January 2010 JD*(A09-1661-01A)

GCE AS/A level 1661/01A APPLIED SCIENCE UNIT 1. Pre-release Article for Examination in January 2010 JD*(A09-1661-01A) GCE AS/A level 1661/01A APPLIED SCIENCE UNIT 1 Pre-release Article for Examination in January 2010 JD*(A09-1661-01A) 2 BLANK PAGE 3 Information for Teachers The attached article on asthma is based on some

More information

COPD MANAGEMENT PROTOCOL STANFORD COORDINATED CARE

COPD MANAGEMENT PROTOCOL STANFORD COORDINATED CARE I. PURPOSE To establish guidelines f the collabative management of patients with a diagnosis of chronic obstructive pulmonary disease (COPD) who are not adequately controlled and to define the roles and

More information

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing ASBESTOSIS November 2013 Bruce T. Bishop Lucy L. Brandon Willcox & Savage 440

More information

An Overview of Asthma - Diagnosis and Treatment

An Overview of Asthma - Diagnosis and Treatment An Overview of Asthma - Diagnosis and Treatment Asthma is a common chronic disorder of the airways that is complex and characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness,

More information

Asthma Intervention. An Independent Licensee of the Blue Cross and Blue Shield Association.

Asthma Intervention. An Independent Licensee of the Blue Cross and Blue Shield Association. Asthma Intervention 1. Primary disease education Member will have an increased understanding of asthma and the classification by severity, the risks and the complications. Define asthma Explain how lungs

More information

Wandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15

Wandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15 Wandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15 April 2015 Dr Kieron Earney & Kate Symons Acknowledgements Dr Sarah Deedat Public Health Lead for Long Term Conditions 1 1.

More information

Pharmacology of the Respiratory Tract: COPD and Steroids

Pharmacology of the Respiratory Tract: COPD and Steroids Pharmacology of the Respiratory Tract: COPD and Steroids Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart

More information

Leanne M Poulos Patricia K Correll Brett G Toelle Helen K Reddel Guy B Marks Woolcock Institute of Medical Research, University of Sydney, NSW

Leanne M Poulos Patricia K Correll Brett G Toelle Helen K Reddel Guy B Marks Woolcock Institute of Medical Research, University of Sydney, NSW Lung disease in Australia Leanne M Poulos Patricia K Correll Brett G Toelle Helen K Reddel Guy B Marks Woolcock Institute of Medical Research, University of Sydney, NSW Prepared for Lung Foundation Australia

More information

HEALTH CARE FOR EXPOSURE TO ASBESTOS. 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun.

HEALTH CARE FOR EXPOSURE TO ASBESTOS. 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun. HEALTH CARE FOR PATIENTS WITH EXPOSURE TO ASBESTOS 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun.ca HEALTH CARE FOR PATIENTS WITH EXPOSURE

More information

SPIROMETRY FOR HEALTH CARE PROVIDERS Global Initiative for Chronic Obstructive Lung Disease (GOLD)

SPIROMETRY FOR HEALTH CARE PROVIDERS Global Initiative for Chronic Obstructive Lung Disease (GOLD) SPIROMETRY FOR HEALTH CARE PROVIDERS Global Initiative for Chronic Obstructive Lung Disease (GOLD) CONTENTS I. INTRODUCTION II. BACKGROUND INFORMATION A. What Is Spirometry? B. Why Perform Spirometry?

More information

Roofers: At Risk for Silicosis Arizona, 2005. Judith Eisenberg, M.D. May 17, 2006 AIHce Silica Roundtable

Roofers: At Risk for Silicosis Arizona, 2005. Judith Eisenberg, M.D. May 17, 2006 AIHce Silica Roundtable Roofers: At Risk for Silicosis Arizona, 2005 Judith Eisenberg, M.D. May 17, 2006 AIHce Silica Roundtable 1 New Respirable Silica Source Phoenix Local of the Roofers Union requested Health Hazard Evaluations

More information

Improving Care for Chronic Obstructive Pulmonary Disease (COPD) Coalition Grant Program PROJECT OVERVIEW & RECOMMENDATIONS

Improving Care for Chronic Obstructive Pulmonary Disease (COPD) Coalition Grant Program PROJECT OVERVIEW & RECOMMENDATIONS Improving Care for Chronic Obstructive Pulmonary Disease (COPD) Coalition Grant Program PROJECT OVERVIEW & RECOMMENDATIONS Executive Summary Chronic Obstructive Pulmonary Disease (COPD) is a common chronic

More information

Insights for Improvement: Advancing COPD Care Through Quality Measurement. An NCQA Insights for Improvement Publication

Insights for Improvement: Advancing COPD Care Through Quality Measurement. An NCQA Insights for Improvement Publication 2009 Insights for Improvement: Advancing COPD Care Through Quality Measurement An NCQA Insights for Improvement Publication Chronic obstructive pulmonary disease (COPD) includes chronic bronchitis, emphysema,

More information

RAND Data: An Example of Population Management. Trina Dutta, MPP, MPH

RAND Data: An Example of Population Management. Trina Dutta, MPP, MPH Strategic Use of Population-Based Information (groups of patients with similar chronic health problems) for Improving Health RAND Data: An Example of Population Management Trina Dutta, MPP, MPH Findings:

More information

Pulmonary Rehabilitation: more than just an exercise prescription

Pulmonary Rehabilitation: more than just an exercise prescription Pulmonary Rehabilitation: more than just an exercise prescription Robert Stalbow, RRT, RCP Pulmonary Rehabilitation Therapist Oregon Heart & Vascular Institute Objectives To describe the role of pulmonary

More information

SARCOIDOSIS. Signs and symptoms associated with specific organ involvement can include the following:

SARCOIDOSIS. Signs and symptoms associated with specific organ involvement can include the following: SARCOIDOSIS Sarcoidosis is a disease that occurs when areas of inflammation develop in different organs of the body. Very small clusters of inflammation, called granulomas, are seen with sarcoidosis. They

More information

National Respiratory (COPD) Framework 2008

National Respiratory (COPD) Framework 2008 National Respiratory (COPD) Framework 2008 Irish Thoracic Society Health Service Executive Irish College of General Practitioners 4926AC42-23BC-281377.doc Table of Contents Acknowledgements 4 Executive

More information

Emphysema. Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects about 64 million people worldwide.

Emphysema. Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects about 64 million people worldwide. Emphysema Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects about 64 million people worldwide. Emphysema involves damage to the air sacs in the lungs. This

More information

Lung Cancer a unique model for disease control A partnership program

Lung Cancer a unique model for disease control A partnership program Lung Cancer a unique model for disease control A partnership program Dr G S Bhattacharyya On behalf of Indian Lung Cancer Task Force The World Economic Forum named NCDs the third largest economic risk

More information

Southwark Clinical Commissioning Group Lambeth Clinical Commissioning Group

Southwark Clinical Commissioning Group Lambeth Clinical Commissioning Group Getting the Vision Right: A multi-disciplinary approach to providing integrated care for respiratory patients Dr Noel Baxter, GP NHS Southwark CCG Dr Irem Patel, Integrated Consultant Respiratory Physician

More information

Smoking Cessation Program

Smoking Cessation Program Guide to Pharmacist Health Coaching Smoking Cessation Program Smoking is the leading cause of preventable death in Canada and a significant risk factor for many chronic non-communicable diseases including

More information

Tests. Pulmonary Functions

Tests. Pulmonary Functions Pulmonary Functions Tests Static lung functions volumes Dynamic lung functions volume and velocity Dynamic Tests Velocity dependent on Airway resistance Resistance of lung tissue to change in shape Dynamic

More information

1 ALPHA-1. Am I an Alpha-1 Carrier? FOUNDATION FOUNDATION. Learn how being an Alpha-1 carrier can affect you and your family

1 ALPHA-1. Am I an Alpha-1 Carrier? FOUNDATION FOUNDATION. Learn how being an Alpha-1 carrier can affect you and your family Am I an Alpha-1 Carrier? 1 ALPHA-1 FOUNDATION The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency and to improving the lives of people affected by Alpha-1 worldwide.

More information

Sponsor Novartis Pharmaceuticals

Sponsor Novartis Pharmaceuticals Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Generic Drug Name Indacaterol Therapeutic Area of Trial Chronic Obstructive Pulmonary Disease (COPD) Indication studied: COPD Study

More information

30 DAY COPD READMISSIONS AND PULMONARY REHAB

30 DAY COPD READMISSIONS AND PULMONARY REHAB 30 DAY COPD READMISSIONS AND PULMONARY REHAB Trina M. Limberg, Bs, RRT, FAARC, MAACVPR Director, Preventative Pulmonary and Rehabilitation Services UC San Diego Health System OVERVIEW The Impact of COPD

More information

TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG

TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG Tx CENTERS Tuberculosis Control Program Health and Human Services Agency San Diego County INTRODUCTION Reducing TB disease requires

More information

Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study

Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study ORIGINAL RESEARCH Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study Robert M Shavelle 1 David R Paculdo 1 Scott J Kush 1 David

More information

written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd

written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd What Is COPD? COPD stands for chronic obstructive pulmonary disease. There are two major diseases included in

More information

MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock Manchester 100 Hitchcock Way Manchester, NH 03104 (603) 695-2850

MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock Manchester 100 Hitchcock Way Manchester, NH 03104 (603) 695-2850 LEBANON Lung Cancer Screening Program One Medical Center Drive Lebanon, NH 03756 (603) 650-4400 (866) 966-1601 Toll-free cancer.dartmouth.edu/lungscreening MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock

More information

COPD PROTOCOL CELLO. Leiden

COPD PROTOCOL CELLO. Leiden COPD PROTOCOL CELLO Leiden May 2011 1 Introduction This protocol includes an explanation of the clinical picture, diagnosis, objectives and medication of COPD. The Cello way of working can be viewed on

More information

IMPOR 'ANT NOTICE NOT TO BE PUBLISHED OPINION

IMPOR 'ANT NOTICE NOT TO BE PUBLISHED OPINION IMPOR 'ANT NOTICE NOT TO BE PUBLISHED OPINION THIS OPINIONIS DESIGNA TED "NOT TO BE PUBLISHED. " PURSUANT TO THE RULES OF CIVIL PROCEDUREPROMULGATEDBY THE SUPREME COURT, CR 76.28 (4) (c), THIS OPINION

More information

COPD It Can Take Your Breath Away www.patientedu.org

COPD It Can Take Your Breath Away www.patientedu.org written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org What Is COPD? COPD stands for chronic obstructive pulmonary disease. There are 2 major diseases included in COPD:

More information

Connect4 Patients CCCM Primary Care Community. Presented By: Veronica Mansfield, DNP, APRN, AE-C, CCM Kit McKinnon, MBA, BSN, RN, CDE, CCM

Connect4 Patients CCCM Primary Care Community. Presented By: Veronica Mansfield, DNP, APRN, AE-C, CCM Kit McKinnon, MBA, BSN, RN, CDE, CCM Connect4 Patients CCCM Primary Care Community Presented By: Veronica Mansfield, DNP, APRN, AE-C, CCM Kit McKinnon, MBA, BSN, RN, CDE, CCM September 17, 2015 Objectives: Describe innovative care management

More information

Brief Tobacco Intervention Online Course

Brief Tobacco Intervention Online Course Brief Tobacco Intervention Online Course Provided by the Kansas Department of Health and Environment 2015 www.kstobaccointervention.org Background An interactive, online course for healthcare providers

More information

Population Health Management Program

Population Health Management Program Population Health Management Program Program (formerly Disease Management) is dedicated to improving our members health and quality of life. Our Population Health Management Programs aim to improve care

More information

Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital

Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Lung Cancer Screening with Low-dose CT Imaging Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Despite recent declines in the incidence of lung cancer related to the

More information

COPD with Respiratory Failure Case Study #21. Molly McDonough

COPD with Respiratory Failure Case Study #21. Molly McDonough COPD with Respiratory Failure Case Study #21 Molly McDonough Patient: Mr. Hayato 65 year old male Brought to ER with severe SOB Past History of emphysema Longstanding chronic obstruction pulmonary disease

More information

PLAN OF ACTION FOR. Physician Name Signature License Date

PLAN OF ACTION FOR. Physician Name Signature License Date PLAN OF ACTION FOR Patient s copy (patient s name) I Feel Well Lignes I feel short directrices of breath: I cough up sputum daily. No Yes, colour: I cough regularly. No Yes I Feel Worse I have changes

More information

Asthma COPD and Asthma - COPD Overlap Syndrome (ACOS)

Asthma COPD and Asthma - COPD Overlap Syndrome (ACOS) Diagnosis of Diseases of Chronic Airflow Limitation: Asthma COPD and Asthma - COPD Overlap Syndrome (ACOS) Based on the Global Strategy for Asthma Management and Prevention and the Global Strategy for

More information

Pulmonary Rehab FAQ s (Abstracted from AACVPR site)

Pulmonary Rehab FAQ s (Abstracted from AACVPR site) (Abstracted from AACVPR site) MAC J-15 Committee 1) Q: Is the 36 session PR program once in a lifetime or per calendar year or per event? Answer: CMS does not limit to one PR course to a calendar year.

More information

J of Evolution of Med and Dent Sci/ eissn- 2278-4802, pissn- 2278-4748/ Vol. 3/ Issue 65/Nov 27, 2014 Page 13575

J of Evolution of Med and Dent Sci/ eissn- 2278-4802, pissn- 2278-4748/ Vol. 3/ Issue 65/Nov 27, 2014 Page 13575 EFFECT OF BREATHING EXERCISES ON BIOPHYSIOLOGICAL PARAMETERS AND QUALITY OF LIFE OF PATIENTS WITH COPD AT A TERTIARY CARE CENTRE Sudin Koshy 1, Rugma Pillai S 2 HOW TO CITE THIS ARTICLE: Sudin Koshy, Rugma

More information

CHAPTER 17: HEALTH PROMOTION AND DISEASE MANAGEMENT

CHAPTER 17: HEALTH PROMOTION AND DISEASE MANAGEMENT CHAPTER 17: HEALTH PROMOTION AND DISEASE MANAGEMENT HEALTH SERVICES AND PROGRAMS The Plan s Health Promotion and Disease Management Department seeks to improve the health and overall well-being of our

More information

COPD. What is COPD? How many people have COPD in Canada? Who gets COPD?

COPD. What is COPD? How many people have COPD in Canada? Who gets COPD? What is COPD? COPD stands for Chronic Obstructive Pulmonary Disease. It is a long-term lung disease that makes it difficult for air to move into and out of the lungs. COPD is used to describe a few lung

More information

RT AS PROJECT MANAGER:

RT AS PROJECT MANAGER: RT AS PROJECT MANAGER: IMPROVING CARE TRANSITIONS DECREASES UNPLANNED READMISSIONS TAMMY JARNAGIN, BHS, RRT DIRECTOR CARDIOPULMONARY SERVICES, NEURODIAGNOSTICS, HOME MEDICAL EQUIPMENT Objectives Recognize

More information

What we will discuss today

What we will discuss today What we will discuss today 1 Who and What is the Canterbury Initiative? 2 How We Work and Areas of Focus 3 Respiratory Service Initiatives and Results to Date 4 Specific Example - Community Screening for

More information

Bronchodilators in COPD

Bronchodilators in COPD TSANZSRS Gold Coast 2015 Can average outcomes in COPD clinical trials guide treatment strategies? Long live the FEV1? Christine McDonald Dept of Respiratory and Sleep Medicine Austin Health Institute for

More information

An Outcomes Strategy for COPD and Asthma: NHS Companion Document

An Outcomes Strategy for COPD and Asthma: NHS Companion Document An Outcomes Strategy for COPD and Asthma: NHS Companion Document 1 DH INFORMATION READER BOX Policy Clinical Estates HR / Workforce Commissioner Development IM & T Management Provider Development Finance

More information

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida Discuss the History of the NFPA 1582 Standard Lance Walker D.O. MPH Identify required elements of a good NFPA program. Look at elements of a good NFPA program Discuss how departments you work with can

More information

Executive Summary... 4

Executive Summary... 4 1 Table of Contents Executive Summary... 4 Section I: The Importance of COPD Disease Management... 6 Why a COPD program?... 6 COPD prevalence... 6 COPD impact... 6 Opportunities for improved COPD management

More information

Smoking and your lungs Why it s never too late to give up

Smoking and your lungs Why it s never too late to give up Smoking and your lungs Why it s never too late to give up Giving up smoking is never easy, but it s the most important thing you can do to look after your health. If you have a lung condition, you might

More information

STATE OF HAWAII DEPARTMENT OF HEALTH P.O. Box 3378 HONOLULU, HAWAII 96801-3378 HOUSE COMMITTEE ON HEALTH SB0654SD1, RELATING TO HEALTH INSURANCE

STATE OF HAWAII DEPARTMENT OF HEALTH P.O. Box 3378 HONOLULU, HAWAII 96801-3378 HOUSE COMMITTEE ON HEALTH SB0654SD1, RELATING TO HEALTH INSURANCE NEIL ABERCROMBIE GOVERNOR OF HAWAII LORETTA J. FUDDY, A.C.S.W., M.P.H. DIRECTOR OF HEALTH STATE OF HAWAII DEPARTMENT OF HEALTH P.O. Box 3378 HONOLULU, HAWAII 9680-3378 In reply, please refer to: File:

More information

Your Go-to COPD Guide

Your Go-to COPD Guide Your Go-to COPD Guide Learning how to live with chronic obstructive pulmonary disease (COPD) Inside, you ll learn: COPD facts COPD symptoms and triggers How to talk with your doctor Different treatment

More information

Clinical Clerkship Curriculum Family Medicine

Clinical Clerkship Curriculum Family Medicine Clinical Clerkship Curriculum Family Medicine AUC Clinical Curricula Guide to Duty Hours, Minimum Experience and Procedure Thresholds, Learner to Teacher Ratios, and Recognition I. In all rotations, AUC

More information

1.1 WHAT IS A QUIT LINE?

1.1 WHAT IS A QUIT LINE? 1.Benefits and rationale for establishing quit-line services 1.1 WHAT IS A QUIT LINE? Quit lines provide a variety of tobacco cessation services predominately via telephones. These usually include: initial

More information

Corporate Medical Policy Genetic Testing for Alpha-1 Antitrypsin Deficiency

Corporate Medical Policy Genetic Testing for Alpha-1 Antitrypsin Deficiency Corporate Medical Policy Genetic Testing for Alpha-1 Antitrypsin Deficiency File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_alpha_1_antitrypsin_deficiency 5/2012

More information

Chronic Obstructive Pulmonary Disease Model of Care. Respiratory Health Network

Chronic Obstructive Pulmonary Disease Model of Care. Respiratory Health Network Chronic Obstructive Pulmonary Disease Model of Care Respiratory Health Network August 2012 Department of Health, State of Western Australia (2012). Copyright to this material produced by the Western Australian

More information

Healthcare provider cessation practices in Ontario. Alexey Babayan Knowledge Exchange Forum June 18, 2014

Healthcare provider cessation practices in Ontario. Alexey Babayan Knowledge Exchange Forum June 18, 2014 Healthcare provider cessation practices in Ontario Alexey Babayan Knowledge Exchange Forum June 18, 2014 What we know Tobacco cessation interventions by healthcare providers (physicians, nurses, dental

More information

COPD. Information brochure for chronic obstructive pulmonary disease.

COPD. Information brochure for chronic obstructive pulmonary disease. COPD Information brochure for chronic obstructive pulmonary disease. CONTENTS What does COPD mean?...04 What are the symptoms of COPD?...06 What causes COPD?...09 Treating COPD...10 Valve therapy in COPD...12

More information

Coding Guidelines for Certain Respiratory Care Services July 2014

Coding Guidelines for Certain Respiratory Care Services July 2014 Coding Guidelines for Certain Respiratory Care Services Overview From time to time the AARC receives inquiries about respiratory-related coding and coverage issues through its Help Line or Coding Listserv.

More information

Tuberculosis Exposure Control Plan for Low Risk Dental Offices

Tuberculosis Exposure Control Plan for Low Risk Dental Offices Tuberculosis Exposure Control Plan for Low Risk Dental Offices A. BACKGROUND According to the CDC, approximately one-third of the world s population, almost two billion people, are infected with tuberculosis.

More information

Understanding COPD. Carolinas Healthcare System

Understanding COPD. Carolinas Healthcare System Understanding COPD Carolinas Healthcare System 2013 This self-directed learning module contains information about the pathophysiology, diagnosis, and treatment of COPD. Target Audience: All RNs and LPNs

More information

PTE Pediatric Asthma Metrics Reporting Updated January 2015

PTE Pediatric Asthma Metrics Reporting Updated January 2015 PTE Pediatric Asthma Metrics Reporting Updated January 20 Introduction: The Maine Health Management Coalition s (MHMC) Pathways to Excellence (PTE) Program is preparing for its next round of PTE Pediatric

More information

STATE PLAN FOR ADDRESSING COPD IN ILLINOIS C O N V E N E D B Y

STATE PLAN FOR ADDRESSING COPD IN ILLINOIS C O N V E N E D B Y STATE PLAN FOR ADDRESSING COPD IN ILLINOIS C O N V E N E D B Y 1440 W. Washington Blvd., Chicago, IL 60607-1878 Phone: (312) 243-2000 Fax: (312) 243-3954 www.lungchicago.org May 2008 Dear Friends: Douglas

More information

Strategies for Improving Patient Outcomes in Pediatric Asthma Through Education. Pediatric Asthma. Epidemiology. Epidemiology

Strategies for Improving Patient Outcomes in Pediatric Asthma Through Education. Pediatric Asthma. Epidemiology. Epidemiology Strategies for Improving Patient Outcomes in Pediatric Asthma Through Education Chris Orelup, MS3 Max Project 3/1/01 Pediatric Asthma The leading cause of illness in childhood 10, 000, 000 school absences

More information

Chronic Obstructive Pulmonary Disease: Epidemiology and Evaluation

Chronic Obstructive Pulmonary Disease: Epidemiology and Evaluation Clinical Review Article Chronic Obstructive Pulmonary Disease: Epidemiology and Evaluation David M. Mannino, MD, FCCP Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction

More information

COPD RESOURCE PACK SECTION 11. Fife Integrated COPD Care Pathways

COPD RESOURCE PACK SECTION 11. Fife Integrated COPD Care Pathways COPD RESOURCE PCK SECTION 11 Fife Integrated COPD Care Pathways In this section: 1. COPD Guidance treatment at each stage of the disease 2. Overview of Respiratory (COPD) Integrated Pathway 3. Chronic

More information

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT

More information

INTRODUCTION. Tobacco Prevention & Cessation Program Substance Abuse and Tobacco Cessation Report - March 2011

INTRODUCTION. Tobacco Prevention & Cessation Program Substance Abuse and Tobacco Cessation Report - March 2011 TPCP Tobacco Prevention & Cessation Program Substance Abuse and Tobacco Cessation Report Report Prepared by Antionne Dewayne Alcorn, BS, CPC, CIT Contributors Miriam N Karanja, MBA Ma rc h 2 0 1 1 INTRODUCTION

More information

Respiratory Conditions in Malaysian Asbestos Cement Workers

Respiratory Conditions in Malaysian Asbestos Cement Workers ORIGINAL ARTICLE Respiratory Conditions in Malaysian Asbestos Cement Workers H H Lim, FAFOM*, KG Rampa!, PhD**, S ]oginder, FRCR***, C M Abu Bakar, MSc****, K H Chan, MBBS*, T N Vivek, MD* Mediviron Consultants

More information

CLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease

CLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease CLINICAL PATHWAY Acute Medicine Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Table of Contents (tap to jump to page) INTRODUCTION 1 Scope of this Pathway 1 Pathway Contacts

More information

Results of Surgery in a New Lung Institute in South Texas Focused on the Treatment of Lung Cancer

Results of Surgery in a New Lung Institute in South Texas Focused on the Treatment of Lung Cancer Results of Surgery in a New Lung Institute in South Texas Focused on the Treatment of Lung Cancer Lung cancer accounts for 13% of all cancer diagnoses and is the leading cause of cancer death in both males

More information

A Telehomecare monitoring project in Cystic Fibrosis

A Telehomecare monitoring project in Cystic Fibrosis ICEHTM 2011 1st International Conference on E-HEALTH and TELEMEDICINE 10-12 October 2011 Nicosia - North Cyprus A Telehomecare monitoring project in Cystic Fibrosis Murgia F, Alghisi F, Majo F, Montemitro

More information